MedCity News February 1, 2024
Molly McGaughan and Kostja Paschalidis

The more pharma companies do to become service providers in the personalized medicine era, the more they’ll succeed and the more lives they’ll help to save.

Personalized medicine is quite possibly the greatest healthcare innovation of our time. It offers the chance to improve and even save the lives of millions of people. But it also presents challenges unlike anything the healthcare establishment has seen. It will take a new form of leadership — including, and especially, from pharmaceutical companies — to bring this innovation to the masses.

As the FDA puts it, precision medicine “is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people’s genes, environments, and lifestyles.” Its goal “is to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Precision Medicine
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
Sylvester Cancer Center Launches Precision-Medicine Focused Brain Tumor Institute
Largest GWAS for Breast Cancer in Women of African Ancestry Reveals Key Variants
New Study Links Ribosomal DNA Copy Number with Disease Risk
Navigating the Complexities of Payment for Genetic Testing

Share This Article